SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053201
Filing Date
2020-11-12
Accepted
2020-11-12 06:08:28
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-10q_20200930.htm 10-Q 2647047
2 EX-31.1 mirm-ex311_6.htm EX-31.1 18651
3 EX-31.2 mirm-ex312_9.htm EX-31.2 18789
4 EX-32.1 mirm-ex321_7.htm EX-32.1 9727
5 EX-32.2 mirm-ex322_8.htm EX-32.2 9719
  Complete submission text file 0001564590-20-053201.txt   7688963

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mirm-20200930.xml EX-101.INS 1484938
7 XBRL TAXONOMY EXTENSION SCHEMA mirm-20200930.xsd EX-101.SCH 54194
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mirm-20200930_cal.xml EX-101.CAL 47275
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mirm-20200930_def.xml EX-101.DEF 190953
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20200930_lab.xml EX-101.LAB 421463
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20200930_pre.xml EX-101.PRE 322874
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 201302972
SIC: 2834 Pharmaceutical Preparations